Alambic Investment Management, L.P. - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 59 filers reported holding NEOS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$19,000
-75.6%
24,689
-52.3%
0.05%
-29.2%
Q4 2019$78,000
-17.0%
51,733
-18.4%
0.06%
-8.5%
Q3 2019$94,000
-66.8%
63,433
-71.0%
0.07%
-59.4%
Q2 2019$283,000
+784.4%
219,090
+1710.7%
0.18%
+1246.2%
Q1 2019$32,00012,1000.01%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,858,889$7,337,0005.11%
Proxima Capital Management, LLC 170,294$257,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 3,530,731$5,331,0000.44%
Nantahala Capital Management 4,610,000$6,961,0000.21%
Wealthstar Advisors, LLC 73,295$111,0000.07%
Alambic Investment Management, L.P. 51,733$78,0000.06%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$151,0000.05%
BCS Wealth Management 29,520$45,0000.03%
Allred Capital Management, LLC 24,995$37,742,0000.02%
ALGERT GLOBAL LLC 34,254$52,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders